Literature DB >> 12434274

[Cardiac manifestations in HIV-infected individual].

Till Neumann1, Birgit Ross, Ulrich R Hengge, Guido Gerken, Raimund Erbel.   

Abstract

The human immunodeficiency virus (HIV) does not only affect the immune system. Other organs including the cardiovascular system are influenced by the HIV as well. Most common HIV-associated cardiac manifestations are pericardial effusion and chronic active, focal or diffuse myocarditis. In addition to peri- and myocardial disease, endocardiac manifestations occur as infective endocarditis and nonbacterial thrombotic endocarditis in HIV-infected patients. Although most of the cardiac manifestations associated with HIV-infection exhibit a slow progression, rapid courses may lead to fatal complications. Early screening of HIV-infected patients will identify the potentially fatal complications of HIV disease and permit efficient treatment. The use of highly active antiretroviral therapy (HAART) significantly reduced the mortality and morbidity of HIV-infected patients. However, the impact that HAART will have on the incidence and prevalence of cardiac complications in HIV-infected patients is still unknown. It can be predicted, that the long-term viral infection and the increase of cardiovascular risk factors by HAART will probably lead to an increased prevalence of HIV-infected individuals with cardiac complications in the next decade. The present review describes the most frequent HIV-associated cardiac manifestations including diagnostic and therapeutic perspectives.

Entities:  

Mesh:

Year:  2002        PMID: 12434274     DOI: 10.1007/s00063-002-1209-x

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  3 in total

Review 1.  Plant glutaredoxins: still mysterious reducing systems.

Authors:  N Rouhier; E Gelhaye; J-P Jacquot
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

2.  [Coronary artery disease in HIV-infected subjects. Results of 101 coronary angiographies].

Authors:  T Neumann; K A Lülsdorf; P Krings; N Reinsch; R Erbel
Journal:  Herz       Date:  2010-12-23       Impact factor: 1.443

Review 3.  [HIV, AIDS and the cardiovascular risk].

Authors:  T Neumann
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.